[12] Patent
[11] Patent No.:GC0009230  
[45] Date of Publishing the Grant of the Patent: 31/Dec /2018                56/2018  
Number of the Decision to Grant the Patent:2018/140685
Date of the Decision to Grant the Patent:02/Dec/2018

[21] Application No.:GCC/P/2007/9629

[22] Filing Date:5/12/2007

[30] Priority:

[33] State [32] Priority date [31] Priority No.
EP
6/12/2006
26125529,5

[72] Inventors:1- Andries, Koenraad Jozef Lodewijk MarcelŲŒ2- Guillemont, Jerome Emile GeorgesŲŒ3- Koul, Anil

[73] Owner: JANSSEN PHARMACEUTICA N. V., Turnhoutseweg 30 B-2340, Beerse, Belgium

[74] Agent: Kadasa Law Firm

  

 

  

[51]IPC:
Int. Cl.7: A61K 31/496; A61P 31/04; C07D 215/14, 401/04, 413/04, 417/04

[56] Cited Documents:

-WO 2005117875 A (JAflSSEN PHAQMACEUTICA NV[BE]; ANDRIES KOENRAAD JOZEF LODEWIJ {BE};VA) 15 December 2005
-WO 2004011436 A {JANSSEN PHARMACEUTICA NV{BE}; VAN GESTEL JOZEF FRANS ELISABE [BE];GU) 5 February 2004
 
Examiner: PH. Rifca AlSadoon

[54] ANTIBACTERIAL QUINOLINE DERIVATIVES
[57] Abstract: The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or formula (Ib): including any stereochemically isomeric form thereof, a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvateas thereof The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
No. of claims: 25


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.